Metformin Hydrochloride
Average across 52 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 79 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | repackager | 63 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 31 | SUPPLYING |
| A-S Medication Solutions | repackager | 28 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 21 | SUPPLYING |
| Proficient Rx LP | repackager | 21 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 19 | SUPPLYING |
| LAURUS LABS LIMITED | unknown | 14 | SUPPLYING |
| Ascend Laboratories, LLC | generic | 13 | SUPPLYING |
| Northwind Health Company, LLC | repackager | 12 | SUPPLYING |
| Unichem Pharmaceuticals (USA), Inc. | unknown | 11 | SUPPLYING |
| AvKARE | relabeler | 10 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 10 | SUPPLYING |
| MARKSANS PHARMA LIMITED | unknown | 9 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 9 | SUPPLYING |
+ 24 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Presence of Foreign Tablets/Capsules. — Recalling firm: A-S Medication Solutions LLC — Nationwide in U.S.
CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit. — Recalling firm: VIONA PHARMACEUTICALS INC — Product was distributed to 17 wholesalers who further distributed the product to 85 locations.
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit. — Recalling firm: VIONA PHARMACEUTICALS INC — Nationwide in the US
Presence of foreign substance: identified as activated carbon. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — USA Nationwide
Failed Moisture Limits: Out of specification for water content — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer) — Recalling firm: Direct Rx — FL
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer) — Recalling firm: PD-Rx Pharmaceuticals, Inc. — AK, AZ, CA, CO, FL, GA, ID, IL, IN, KY, MN, NC, NY, OK, OR, WI
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer) — Recalling firm: PD-Rx Pharmaceuticals, Inc. — AK, AZ, CA, CO, FL, GA, ID, IL, IN, KY, MN, NC, NY, OK, OR, WI
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Marksans Pharma Limited — Nationwide
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Marksans Pharma Limited — Nationwide
CGMP Deviations — Recalling firm: BAYSHORE PHARMACEUTICALS — nationwide
CGMP Deviations — Recalling firm: BAYSHORE PHARMACEUTICALS — nationwide
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed throughout the United States.
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed throughout the United States.
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed throughout the United States.
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed throughout the United States.
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed throughout the United States.
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: PD-Rx Pharmaceuticals, Inc. — United States.
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Marksans Pharma Limited — Nationwide
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Amneal Pharmaceuticals of New York, LLC — Nationwide
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Amneal Pharmaceuticals of New York, LLC — Nationwide
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level — Recalling firm: Amneal Pharmaceuticals of New York, LLC — Nationwide
